Separation of foot-and-mouth disease virus leader protein activities; identification of mutants that retain efficient self-processing activity but poorly induce eIF4G cleavage by Belsham, Graham & Hua Guan, Su
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 18, 2017
Separation of foot-and-mouth disease virus leader protein activities; identification of
mutants that retain efficient self-processing activity but poorly induce eIF4G cleavage
Belsham, Graham; Hua Guan, Su
Published in:
Journal of General Virology
Link to article, DOI:
10.1099/jgv.0.000747
Publication date:
2017
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Belsham, G., & Hua Guan, S. (2017). Separation of foot-and-mouth disease virus leader protein activities;
identification of mutants that retain efficient self-processing activity but poorly induce eIF4G cleavage. Journal of
General Virology, 98, 671-680. DOI: 10.1099/jgv.0.000747
Downloaded from www.microbiologyresearch.org by
IP:  192.38.90.17
On: Wed, 17 May 2017 09:35:03
Separation of foot-and-mouth disease virus leader protein
activities; identification of mutants that retain efficient self-
processing activity but poorly induce eIF4G cleavage
Su Hua Guan and Graham J. Belsham*
Abstract
Foot-and-mouth disease virus is a picornavirus and its RNA genome encodes a large polyprotein. The N-terminal part of this
polyprotein is the leader protein, a cysteine protease, termed Lpro. The virus causes the rapid inhibition of host cell cap-
dependent protein synthesis within infected cells. This results from the Lpro-dependent cleavage of the cellular translation
initiation factor eIF4G. Lpro also releases itself from the virus capsid precursor by cleaving the L/P1 junction. Using site-
directed mutagenesis of the Lpro coding sequence, we have investigated the role of 51 separate amino acid residues in the
functions of this protein. These selected residues either are highly conserved or are charged and exposed on the protein
surface. Using transient expression assays, within BHK-21 cells, it was found that residues around the active site (W52, L53
and A149) of Lpro and others located elsewhere (K38, K39, R44, H138 and W159) are involved in the induction of eIF4G
cleavage but not in the processing of the L/P1 junction. Modified viruses, encoding such amino acid substitutions within Lpro,
can replicate in BHK-21 cells but did not grow well in primary bovine thyroid cells. This study characterizes mutant viruses
that are deficient in blocking host cell responses to infection (e.g. interferon induction) and can assist in the rational design
of antiviral agents targeting this process and in the production of attenuated viruses.
INTRODUCTION
Foot-and-mouth disease (FMD) is one of the most feared
diseases of livestock animals. It is caused by FMD virus
(FMDV), which can infect more than 70 different species
including cattle, swine and sheep [1]. The disease can sig-
nificantly impact the economy of affected countries [2].
FMDV is the prototypic member of the genus Aphthovirus
within the family Picornaviridae. The genome of FMDV is
a positive-sense, single-stranded RNA of about 8400
nucleotides (nt) and in the virus particle the viral RNA is
enclosed within a protein shell (capsid) that includes 60
copies of each of the four structural proteins VP1, VP2,
VP3 and VP4 [3].
The genome includes a single, large, open reading frame
(ORF), circa 7000 nt, that encodes a polyprotein (circa 2330
residues). Translation of the RNA is initiated at two differ-
ent AUG codons that are 84 nt apart, yielding two alterna-
tive forms of the N-terminal component of the polyprotein,
namely the leader protease (Lpro); these are termed Lab (201
amino acids) and Lb (173 amino acids) [4, 5]. The 84 nt
spacer region (encoding 28 amino acids) is not required for
virus viability but could have a role that is separate from its
coding function, since deletion of the entire Lab sequence is
not tolerated, whereas viruses lacking the 84 nt spacer
region alone or the complete Lb coding sequence are viable
within baby hamster kidney cells (BHK-21) [6]. Both forms
of Lpro are identical at their C-termini and appear to display
the same functions [7]. Lpro cleaves itself from the nascent
capsid protein precursor P1-2A [8]. In addition, Lpro also
induces the cleavage of the two homologues of a host cell
translation initiation factor, termed eIF4GI [9] and eIF4GII
[10]; these are around 46% identical. This cleavage sepa-
rates the N-terminal domain of eIF4G, which is responsible
for attachment to the cap-binding protein eIF4E, from the
rest of the molecule. This process results in the shut-off of
host cell cap-dependent mRNA translation, a common hall-
mark of picornavirus infection [11]. In contrast, the initia-
tion of translation on picornavirus RNA is achieved
through a cap-independent mechanism directed by an inter-
nal ribosomal entry site (IRES) located within the 5¢-
untranslated region (UTR) and this process is maintained
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following cleavage of eIF4G (e.g. see [11, 12]). FMDV 3Cpro
has also been shown to induce cleavage of eIF4G [13], at
least in cells from certain species (e.g. BHK-21). This occurs
on the C-terminal side of the site generated by the expres-
sion of the Lpro and this cleavage occurs after the Lpro-medi-
ated cleavage is complete (see [14]). Cleavage of eIF4GI
induced by Lpro can be observed even in the absence of virus
replication, when virus protein expression is very low [13].
Besides the FMDV protease, the Lpro of other members of
the genus Aphthovirus, namely bovine rhinitis B virus
(BRBV) and equine rhinitis A virus (ERAV), also induce
eIF4G cleavage [15, 16].
In addition to these activities, the FMDV Lpro has also been
reported to inhibit NF-kB activation [17] and to exhibit
deubiquitinase (DUB) activity for certain critical signalling
proteins of the type I interferon (IFN) signalling pathway
[18]. Modification of the I83AL86A motif within a SAP (for
SAF-A/B, Acinus, and PIAS) domain of Lpro has been
reported to abrogate the DUB activity as well as its ability to
block signalling to the IFN-b promoter [18].
Lpro is a papain-like cysteine proteinase with a flexible C-
terminal extension (CTE) of 18 amino acid residues
(Asp184-Lys201); the three-dimensional (3D) structure of
the FMDV Lbpro has been determined [19]. The critical
active site residues are Cys51 and His148 [20, 21]. Substitu-
tion of either of these residues ablates the Lpro catalytic
activities. The L/P1 cleavage site is well characterized; cleav-
age occurs at either a K/G or R/G junction (in different
strains of FMDV, see [22]) and the cleavage can occur in
trans [7] but also probably in cis. In contrast, the cleavage
sites within the two distinct forms of eIF4G (eIF4GI and
eIF4GII) are less well understood. Studies with eIF4GI iden-
tified a cleavage site produced in vitro by purified, recombi-
nant, L protease as ANLG/RTTL [23]; however later studies
on the closely related eIF4GII identified a cleavage site as
LNVG/SRRS [10]. This cleavage site is not in the equivalent
position to that in eIF4GI. It is possible that the cleavage of
eIF4GI and eIF4GII occurs through an indirect mechanism
(i.e. mediated by another protease, see [24]). Another cellu-
lar protein, Gemin5, has also been shown to be cleaved in
the presence of the FMDV Lpro [25]. Whatever the mecha-
nism, it is apparent that the recognition of the cellular pro-
tein substrates by the FMDV Lpro has to be significantly
different from the recognition of the L/P1 junction within
the viral polyprotein. Indeed, there is evidence that cleavage
of the L/P1 junction in vitro can be affected without impact
on eIF4G processing, and vice versa. Mutations Y168F and
D163N clearly slowed the self-processing activity at the L/
P1 junction but not eIF4G cleavage in cell-free extracts [26].
In contrast, deletion of the CTE or the presence of a modi-
fied C-terminus (Lpro+9) greatly slowed the induction of
eIF4G cleavage but these modifications do not affect the
ability of mutants to process the polyprotein substrate
in vitro [27]. Thus, it should, in principle, be possible to
define specific features (i.e. individual amino acid residues)
of the Lpro that differentially affect the cleavage of the dis-
tinct cellular and viral protein substrates within cells.
It has been shown that the sequence between two initiation
codons of Lpro is not essential for its cleavage functions [6,
7]. Therefore, the coding region of Lb was chosen as the tar-
get for mutational analysis in this study. Despite sharing
protease activities, only 44% of the residues in Lbpro were
invariant among about 100 different FMDV isolates repre-
senting each of the seven different serotypes [22]. Using
site-directed mutagenesis of the FMDV cDNA, we have
now substituted both surface exposed and conserved resi-
dues within Lbpro and examined the properties of the
mutant proteins that were generated using transient expres-
sion assays within cells. Selected modifications were also
analysed in the context of the infectious virus and the influ-
ence of these modifications on the replication of FMDV was
determined.
RESULTS
Screening for amino acid substitutions that
differentially affect activities of FMDV Lb
pro
As indicated above, many residues within the Lbpro are vari-
able between different strains of FMDV. To identify resi-
dues that modify the substrate specificity of the Lpro, the
conserved amino acids and the hydrophilic residues that are
exposed to the aqueous solvent on the protein were located
using the known 3D structure [19]. Codons corresponding
to the selected residues were modified, using site-directed
mutagenesis of cDNA including the L/VP4 coding region.
In total, mutations encoding 51 different amino acid substi-
tutions (out of 173 residues in Lb) were made (Fig. 1,
Table 1).
As an initial screen, to analyse the properties of the mutant Lb
proteins, BHK-21 cells [infected with the recombinant vac-
cinia virus vTF7-3, which expresses the T7 RNA polymerase
(see [28])], were transfected with the mutant Lproexpression
plasmids together with a dicistronic luciferase reporter plas-
mid (pFluc/EMCV/Rluc, [29]). This plasmid expresses a dicis-
tronic mRNA that encodes both firefly luciferase (Fluc) and
Renilla luciferase (Rluc). The production of the latter is depen-
dent on the activity of the IRES while the Fluc expression is
achieved by cap-dependent translation initiation. The ratio of
Fluc to Rluc activity observed in the presence of the catalyti-
cally inactive C51A mutant was set to 100% and the relative
levels of Fluc in the presence of the other forms of Lb were cal-
culated and are shown in Table 1. The C51A mutant is modi-
fied at one of the two critical active site residues within Lpro
[20]. Wild-type (wt) Lpro, which induces eIF4G cleavage,
strongly inhibited (to about 10% of that seen with the C51A
mutant) the cap-dependent expression of Fluc, as expected. In
contrast, 19 mutant plasmids that were constructed in this
study encoding the substitutions K38EK39E, K38EK39T,
W52A, L53S, Q58EL59A, Q58E, A149D, G158AW159A,
W159A, N46Q, D136A, D136AF137A, F137AH138A,
H138P, V103AW105A, F151A, D164A, D163AD164AE165A
and P182AD184AP187A within Lbpro had rather limited or
Guan and Belsham, Journal of General Virology 2017;98:671–680
672
Downloaded from www.microbiologyresearch.org by
IP:  192.38.90.17
On: Wed, 17 May 2017 09:35:03
no inhibitory effect on Fluc expression (similar to that
observed with the mutant C51A, see Table 1). This indicates
that these modifications abrogated the negative effect of Lpro
on cap-dependent translation. In contrast, the other 35
mutants of Lbpro produced a strongly negative impact on Fluc
expression (less than 50% of the Fluc activity seen with the
C51A mutant, see Table 1).
To confirm and extend the analysis of the functionality of
the Lpro mutants, the L/VP4 cleavage activity and the induc-
tion of eIF4GI cleavage within transfected BHK-21 cells
were assessed for selected variants of the FMDV Lb. For
these analyses, plasmids that express, from the T7 promoter,
RNA transcripts containing the FMDV IRES (to maintain
expression when eIF4G is cleaved) followed by the coding
region for L/VP0 with a C-terminal FLAG epitope tag
(termed L/VP0-FLAG) were used (Fig. 2a). Cells, infected
with vTF7-3 as above, were transfected with the wt or
mutant plasmids and cell extracts, prepared 20 h later, were
analysed by immunoblotting using anti-eIF4GI and anti-
FLAG antibodies. The properties of the mutant Lb proteins
were compared to the wt protein and to the Lpro C51A
mutant. As shown in Fig. 2(b), nearly all the tested mutant
proteins (other than C51A) retained the L/VP4 self-cleavage
activity since the FLAG-tagged VP0 was produced in each
case. One exception was the Q58EL59A mutant, which had
lost this function (n.b., in principle, the L/VP0 cleavage can
occur either in cis or in trans in these assays since multiple
copies of each mutant protein are made in the cells). Expres-
sion of the wt Lpro resulted in complete loss of the intact
eIF4GI and the production of a specific cleavage product
(Cp) whereas no loss of the intact eIF4GI was observed
when the C51A mutant was expressed (Fig. 2c), as expected.
Mutants K39E, R44A, N46Q, V103AW105G and F151A
each induced quite high levels of eIF4GI cleavage but some
residual intact protein was apparent. In contrast, only low
levels of the eIF4GI Cp were observed with the mutants
K38EK39E, R44AH138A, W52A, L53S, Q58EL59A, A149D
and W159A (Fig. 2c).
To test whether the mutations within the Lb coding region
affect the L/VP0 cleavage in trans, the Lpro C51A-VP0 plas-
mid was co-transfected with two different amounts of the
Lbpro mutant plasmids. The plasmids tested were selected
because each induced a very low level of eIF4GI cleavage
activity in BHK-21 cells. The results (see Fig. 2d) showed
that complete cleavage of the L/VP0 junction occurred with
each of the mutants tested (except for C51A) when using
the higher level of the plasmid. However, when a low level
of the mutant Lb expression plasmid was used, then high
levels of the uncleaved L/VP0 were observed for the W52A
and L53S mutants and some precursor was also apparent
with each of the other mutants tested as well (except
for A149D). In contrast, Lpro C51A-VP0 was cleaved
completely even in the presence of the low amount of wt
Lpro plasmid (Fig.2d). Thus, these results showed the W52A
and L53S amino acid substitutions impaired the in trans
cleavage activity to some degree but did not block it
completely, while the other selected mutants retained the
ability to cleave the L/VP0 junction efficiently in trans.
Influence of the L
pro
modifications on virus
replication
To determine the importance of the modifications of Lpro
activity in the context of the infectious virus, selected muta-
tions (encoding the substitutions K38EK39E, R44AH138A,
W52A, L53S, A149D and W159A) were introduced into the
full-length cDNA of FMDV [strain O1 Kaufbeuren (O1K)].
Each of the variants selected retained the ability to cleave
the L/VP0 junction; if this activity is lost it is highly unlikely
that an infectious virus could be produced since this would
prevent correct production of the virus capsid protein pre-
cursor P1-2A. Using these plasmids, full-length RNA tran-
scripts were produced in vitro and then introduced into
Fig. 1. The amino acid sequence of FMDV Lpro indicating targeted residues. The asterisks indicate the key catalytic residues (C51 and
H148). Underlined residues are conserved among FMDV strains [22]. Residues in bold, italics were modified in this study. The
sequence represents the complete Lab form of the protease; the Lb form lacks the N-terminal 28 amino acids.
Guan and Belsham, Journal of General Virology 2017;98:671–680
673
Downloaded from www.microbiologyresearch.org by
IP:  192.38.90.17
On: Wed, 17 May 2017 09:35:03
BHK-21 cells by electroporation. As judged by the produc-
tion of cytopathic effect (CPE) (passage 3), rescued viruses
were obtained in each case. The virus stocks were titred and
the presence of only the expected mutations within the Lpro
coding sequence of the rescued viruses was confirmed by
sequencing [following reverse transcription PCR (RT-PCR),
data not shown]. The mutant viruses were then used to
infect IBRS-2 cells (note in these cells, in contrast to BHK-
21 cells, the FMDV 3Cpro does not induce eIF4G cleavage)
[14]. Consistent with the results described above, the modi-
fications to Lpro tested here had almost no impact on self-
processing at the L/VP4 junction, as shown in Fig. 3(a),
since VP0 (without L) was released from the polyprotein in
each case.
As expected, with the wt Lpro, the cellular eIF4GI was
largely cleaved at 2 h post infection (h.p.i.) and was
completely processed at 4 h.p.i. In contrast, in uninfected
cells or within cells infected with a mutant FMDV lacking
the Lb coding region (DLb, [6]) the eIF4GI remained
intact through to 6 h.p.i. The rescued viruses with just 1
or 2 amino acid substitutions within Lpro were much less
efficient at producing eIF4G cleavage than the wt virus.
Although some cleavage was detectable at 2 h.p.i. with
mutants K38EK39E and A149D or at 4 h.p.i. (mutants
R44AH138A, W52A, L53S, and W159A), intact eIF4GI
persisted throughout the course of infection (up to 6 h.p.
i.) for all of the mutants (Fig. 3b).
Time course of FMDV replication in pBTY cells
Primary bovine thyroid (pBTY) cells have been shown to be
the most sensitive cell type for detecting field strains of all
seven serotypes of FMDV [30]. However, as shown previ-
ously [6], the presence of a functional Lb protease is
required for the virus to grow efficiently in pBTY cells. In
this study, some CPE was observed in wt FMDV-infected
pBTY cells at 10 h.p.i., and by 23 h.p.i. most of the mono-
layer was affected. In contrast, using the FMDV lacking the
Lb coding region (DLb, [6]) and also the FMDVs with Lpro
point mutants described above, >90% of the pBTY cells
were still unaffected visually by 23 h.p.i. However, in
Table 1. Effect of wt and mutant Lpro expression on cap-dependent
translation in BHK-21 cells
The grey blocks indicate the modifications of Lbpro that allow efficient
cap-dependent translation of Fluc and were selected for further analy-
sis. Data are presented as the mean±SD from the indicated number of
independent experiments.
Amino acid substitutions Relative Fluc
expression (%)
No. of observations
C51A 100 12
wt 10±2 6
K38A 17±2 3
K39E 34±4 3
K39A 36±9 3
K38AK39T 24±1 4
K38EK39T 66±11 3
K38EK39E 80±4 3
R44A 52±18 3
N46Q 63±13 3
D49A 25±11 3
W52A 96±5 3
L53S 97±6 3
L57A 21±10 3
Q58A 26±6 3
Q58E 79±13 3
L59A 38±5 4
Q58EL59A 93±12 3
R61T 27±8 3
D69A 24±7 3
E81A 22±10 3
K84A 23±9 3
D88A 20±14 3
D88AE96A 12±3 3
P99A 12±3 3
V103A 14±6 4
V103AW105G 92±13 3
K108A 19±7 3
T113A 19±6 3
R120A 19±5 3
P121A 30±2 3
E123A 19±5 3
D128A 39±10 3
G129A 25±7 3
L134A 35±6 3
D136A 87±11 3
H138P 92±8 3
D136AF137A 88±8 3
F137A H138A 78±13 3
E147A 15±2 3
E147AK144E 21±5 3
A149D 72±10 3
F151A 60±11 3
G158A 42±8 4
G158AW159A 92±8 3
W159A 99±2 3
D164A 95±7 3
Table 1. cont.
Amino acid substitutions Relative Fluc
expression (%)
No. of observations
E165A 21±11 3
D163AD164AE165A 100±0 3
P169AT171A 30±11 3
D173A 20±3 3
L178A 25±6 3
P187A 18±2 3
P182AD184AP187A 95±9 3
D184AE186A 44±2 3
L188A 22±4 3
E191AK193EK195A 20±5 3
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BHK-21 cells, each of the viruses (wt and mutants) induced
80–90%CPE by 23 h.p.i. (data not shown).
To analyse, in more detail, the growth characteristics of the
mutant O1K viruses, with just one or two amino acid sub-
stitutions in the Lpro, we infected, at low m.o.i. (0.01 TCID50
cell 1), both pBTY cells (Fig. 4a) and, in parallel, BHK-21
cells (Fig. 4b). The replication of each virus was measured
using quantitative real-time RT-PCR (RT-qPCR) assays
that determine the level of FMDV RNA within the samples
collected at multiple time points after the start of the infec-
tion. In BHK-21 cells, each of the viruses grew with similar
kinetics but it was noted that by 10 h.p.i., the level of wt
FMDV RNA accumulated to higher levels than for the Lpro
mutants. As shown in Fig. 4(a), wt FMDV also grew well in
pBTY cells. However, in contrast, little or no amplification
of any of the Lpro mutant viruses was observed beyond 5 h.
p.i. (Fig. 4a).
DISCUSSION
The 3D structure of Lbpro includes an active site with the
two key catalytic residues, C51 and H148, on the opposite
sides of a cleft separating two domains, an a-helical
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Fig. 2. Determination of L/VP0 and eIF4GI cleavage within BHK-21 cells expressing wt and mutant Lpro (a) Structure of the Lpro
expressing plasmid. Fragments containing cDNA corresponding to the FMDV IRES upstream of the coding region for wt or mutated Lpro
followed by VP0 and the FLAG epitope tag were inserted into pGEM-3Z, downstream of a T7 promoter, between EcoRI and BamHI
sites. (b) Cleavage of the L-VP0 junction by selected Lpro mutants. Cells, infected with vTF7-3, were transfected with the indicated plas-
mids and extracts were prepared 20 h later and analysed by SDS-PAGE and immunoblotting using an a-FLAG antibody. (c) Cleavage of
eIF4GI induced by selected Lpro mutants. Samples prepared as described for panel (b) were analysed by immunoblotting using an
a-eIF4GI antibody. The cleavage product of eIF4GI is indicated by Cp. (d) Effect of mutations on Lpro self-processing in trans. The Lpro
C51A-VP0 plasmid was cotransfected with two different amounts (50 ng and 300ng) of the indicated Lpro mutant plasmids. The
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domain and b-sheet domain including the C-terminal
region with a unique CTE (Fig. 5a). Residues 183–195 of
the CTE have been shown to be important for the
interaction with eIF4GI [27]. The Lbpro with only a partial
CTE (residues 183–195) retained the activities of wt Lbpro,
whereas deletion of the entire CTE reduced the ability to
induce cleavage of eIF4G. Modification of residue C133,
which is structurally close to the CTE, produced similar
results in vitro [31]. Further study indicated that the con-
served residues D184 and E186 within the CTE were
important for this loss of function [32].
Some studies have indicated that the cleavage of eIF4G
induced by the FMDV Lpro requires the interaction of
eIF4G with the cap-binding protein eIF4E [33]; this transla-
tion initiation factor binds to the N-terminal region of
eIF4G. Recent studies have shown that interaction of Lbpro
with a short fragment of eIF4GII requires the presence of
eIF4E [34], within a heterotrimeric complex, and that resi-
due C133 and the CTE of Lbpro are required for the interac-
tion with eIF4E. However, these experiments were based on
the use of rabbit reticulocyte lysate (RRL) in vitro transla-
tion system and were focused on the CTE and residues
around the active site. Here we have investigated the con-
served and charged amino acid residues distributed across
the surface of the Lpro structure and generated an insight
into the roles of these residues in producing cleavage of
eIF4G within cells.
Compared to other papain-like proteases, Lpro displays a
deeper and narrower cleft (S1 subsite) with the active site at
the bottom, the loop preceding the central helix a1 (N50–
E61) on one side, and the b-turn connecting strands b5 and
b6 (F137–S156) on the other [19]. Among the residues
involved in this subsite, the amino acid substitutions W52A,
L53S, Q58EL59A, and A149D each led to the loss of eIF4G
cleavage activity (see Fig. 2c). The double mutant
Q58EL59A also failed to release Lpro from the polyprotein.
These key residues are all located in the vicinity of the active
site (see Fig. 5a) and may contribute to the substrate
eIF4G
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FMDVs, as indicated, at an m.o.i. of 2. Cytoplasmic extracts were prepared at the indicated times post-infection and analysed by SDS-
PAGE and immunoblotting. (a) Lpro self-processing at the L/P1 junction to produce VP0 was detected using an a-FMDV VP2 antibody.
(b) eIF4GI cleavage induced by the expression of wt and mutant FMDV Lpro was detected using an a-eIF4GI antibody.
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cells. The rescued wt and mutant FMDVs, as indicated, were used to
infect pBTY cells (a) or BHK-21 cells (b) at an m.o.i. of 0.01 TCID50
cell 1, and harvested after freezing from 0 to 23 h later. Total RNA
was extracted and the level of FMDV RNA was measured using RT-
qPCR assays and is expressed as RNA copies per ml of virus harvest.
Results are representative of three separate experiments.
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recognition since (apart from the double mutant) they do
not affect the L/P1 cleavage activity; thus they do not affect
the catalytic activity of the enzyme per se. It is noteworthy
that these residues are highly conserved in FMDV [22] and
they (except W52 and A149) are also present in the equiva-
lent positions within the L protease of ERAV but not in the
Lpro of equine rhinitis B virus (ERBV) [16]. Unlike the
ERBV Lpro, which is unable to shut down cellular cap-
dependent translation, the ERAV Lpro and FMDV Lpro both
induce cleavage of eIF4GI at very similar or identical posi-
tions [16]. Taken together, these observations are consistent
with a significant role for these residues, around the S1 sub-
site, in the induction of eIF4G cleavage by Lpro.
Residues W52 and A149 are also involved in the S2 subsite,
a deep hydrophobic pocket [19]. A comparison between the
monomeric Lbpro L200F and sLbpro (lacking the last six resi-
dues of Lbpro) showed that residue W52 displayed a signifi-
cant backbone amide shift when the C-terminal residues
were removed [35], suggesting an interaction between W52
and the CTE. Moreover, W52 is adjacent to the catalytic res-
idue C51. These properties may contribute to the loss of
eIF4G cleavage observed with the mutant W52A; however
the L/P1 cleavage activity was retained by this mutant so the
enzyme is clearly still active (c.f. the C51A mutant). The
conserved residue A149 is adjacent to the other key catalytic
residue H148. Modification of A149 to the charged Asp
(A149D) resulted in delayed eIF4G cleavage (Fig. 3b). This
modification changes the hydrophobic environment and the
acidic side chain of Asp may modify the space for the sub-
strate to penetrate into the S2 pocket. Indeed, clear chemical
shifts were observed for residues involved in the S2 pocket
in the presence of a 12 amino acid peptide derived from
eIF4GI [36].
In this study, we have also shown the importance of residues
K38, K39 and R44 for the Lbpro- induced cleavage of eIF4G.
It seems that an acidic side chain (as in Glu, E) is not toler-
ated in place of K38 or K39. The double substitutions
K38EK39E significantly impaired the cleavage of eIF4G
(Fig. 3b, c). However, this was not the case for the single-
point mutants K38A and K39A (n.b. these changes intro-
duce a neutral amino acid rather than an acidic residue),
which both significantly inhibited the expression of Fluc,
reflecting loss of intact eIF4G (Table 1). It could be that the
double substitutions K38AK39A would have a similar effect
to K38EK39E on eIF4G cleavage induced by Lbpro. How-
ever, the mutant K38AK39T that has lost both the basic
side chains impaired cap-dependent translation (as moni-
tored by Fluc expression, see Table 1). The substitution
K39E alone or in K38EK39T has a clear negative impact on
Fluc expression (Table 1) and induced eIF4G processing
albeit these effects were weaker than with the wt Lpro. There-
fore, it appears that the double substitutions in K38EK39E
change the local ionic environment leading to a reduction in
the Lpro-induced eIF4G cleavage activity.
Amino acids R44 and H138 are conserved, charged residues
within Lb. It is apparent from the 3D structure that, like
K38 and K39, the side chain of R44 protrudes away from
the globular domain of Lpro (Fig. 5b) and none of these resi-
dues appears to interact with the CTE [19]. Instead, these
basic side chains are well positioned to interact with
C51
H148
W52
(a) (b)
L59
K39
K38
H138
W159
R44
A149
CTE
Q58
L53
W159
L134
F137
V154
K39
K38
R44
CTE
C133
Fig. 5. Location of residues affecting induction of eIF4G cleavage. (a) 3D structure of Lbpro [19] (PDB ID code 1QOL, annotated using
PyMol). The two critical active site residues (C51 and H148) are marked in red. Residues coloured yellow were demonstrated in this
study to play an important role in eIF4GI cleavage. (b) Hydrophobic region. Residues in purple form a hydrophobic region with residue
W159.
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residues from another protein. However, the interaction
may be not very strong or at least involve more than one
residue. It is apparent that single mutants K39E and R44A
did not reduce the eIF4G cleavage as much as the double
mutants K38EK39E and R44AH138A. These results are
consistent with previous observations that the mutant
H138L was reduced in its ability to induce eIF4G cleavage
but did not affect self-processing activity [21].
Residue W159 was investigated here due to its conservation
in FMDV, BRBV and ERAV (data not shown). The modifi-
cation W159A greatly decreased the eIF4G cleavage induced
by Lpro compared to wt. The cleaved product could only be
observed from 6 h.p.i. in virus-infected cells (Fig. 3b). The
side chain of W159 together with residues L134, F137 and
V154 form a very hydrophobic region within the structure
of Lpro (Fig. 5b). Studies using NMR showed amide chemi-
cal shift changes for these residues in the presence of an
eIF4GI-derived 12mer peptide [36], suggesting the possible
involvement of these residues in substrate interaction.
Indeed, as shown here, the substitutions in mutant
D136AF137A resulted in the high cap-dependent expres-
sion of Fluc (Table 1) (i.e. reflecting poor eIF4G cleavage).
From closer investigation of the 3D structure, it was found
that in addition to the residues that are close to the active
site (W52, L53 and A149), residues located on b-sheets
(K39, R44, C133, F137, H138 and W159) form a surface-
like region. Moreover, this region is highly conserved, indi-
cating that this surface may play a significant role in the
protein interactions required for cleavage of eIF4G.
Some of the mutants generated in this study have been
shown to be tolerated within the context of infectious
FMDV in BHK-21 cells but these mutant viruses have lost
their ability to replicate well in pBTY cells. This may be due
to their failure to induce eIF4G cleavage efficiently; conse-
quently, the mutant FMDVs can be expected to fail to
inhibit interferon production [37]. Thus these studies may
facilitate the development of effective new strategies that
target Lpro for the control of FMDV infection. Furthermore,
the characterization of such mutant viruses can contribute
to the development of engineered, attenuated viruses that
can be grown, e.g. for vaccine antigen production, outside of
high containment facilities.
METHODS
Construction of plasmids containing mutations
in the Lb
pro
coding region
The plasmid pT7S3 [38] contains the full-length cDNA for
the O1Kaufbeuren B64 strain of FMDV. To modify the
Lbpro coding region, a KpnI fragment (circa 1.4 kb) from
pT7S3 was inserted into KpnI-digested pGEM3Z (Prom-
ega), generating pSG2. The nucleotides encoding the tar-
geted amino acids within the coding region of Lbpro were
modified by site-directed mutagenesis [39]. Briefly, frag-
ments were amplified using pSG2 as template with forward
primers carrying mutations (Table S1, available in the
online Supplementary Material) and a reverse primer (SP6)
in separate PCRs. The amplicons were gel purified and used
as megaprimers for the second round of amplifications
again using pSG2 as the template. The PCR products were
digested with DpnI, to remove the template DNA, and then
transformed into competent E. coli. Plasmid DNAs isolated
from the resultant colonies were then sequenced using pri-
mers T7 and SP6 to confirm the presence of the expected
mutations and the absence of other changes.
To facilitate the analysis of L/P1 cleavage activity, a FLAG-
epitope tag was introduced at the C-terminus of the coding
region for the VP2 capsid protein. Thus, the cDNA frag-
ment corresponding to the IRES followed by the L/VP4/
VP2 (L-VP0) coding region was amplified using primers
SG1 and SG42 with the plasmid pT7S3 (as above) as tem-
plate. The fragment (2007 bp) was digested with EcoRI and
BamHI and ligated into similarly digested pGEM3Z, gener-
ating pSG42. Individual mutations within the Lb coding
region were introduced by site-directed mutagenesis and
resulted in the following substitutions: C51A, W52A, L53S,
K38EK39E, Q58EL59A, A149D and W159A (following the
numbering system for the Lab form of Lpro). Briefly, primers
10PPN36 and SG57 (Table S1), and the derivatives of pSG2
carrying the mutations were used as the templates to gener-
ate megaprimers for the second round PCRs. The template
in the second round of PCR was pSG42. The final constructs
were sequenced throughout the L/VP2 coding region using
primers SG1 and SG42.
Transient expression assays
Plasmid DNAs were transfected, using FuGene 6 (Promega)
as described by the manufacturer, into BHK-21 cells
(35mm wells, circa 90% confluent) that had been infected
with the recombinant vaccinia virus vTF7-3 [28] which
expresses the T7 RNA polymerase essentially as described
[29]. For the luciferase assays, the pSG2 variants with muta-
tions in Lbpro (30 ng) were co-transfected with pFluc/
EMCV/Rluc (2 µg) (this expresses both firefly and Renilla
luciferase; [29]). Inhibition of cap-dependent translation
was monitored by measuring Fluc expression relative to the
Rluc expression. The cap-independent expression of the
Rluc is directed by the EMCV IRES. At 20 h.p.i., cell lysates
were prepared using the Rluc assay lysis buffer for Fluc and
Rluc assays, or using buffer C [20mM Tris-HCl (pH 8.0),
125mM NaCl, and 0.5% NP-40] for Western blot analysis,
and extracts were clarified by centrifugation at 18 000 g for
10min at 4

C.
Luciferase reporter assays
Fluc and Rluc activities were determined using the firefly
and Renilla reporter assay systems (Promega), respectively,
according to the manufacturer’s protocol. The Fluc activities
were normalized to the measured Rluc activities and the
data were collected from at least three independently con-
ducted experiments.
Immunoblotting
Immunoblotting was performed according to standard
methods as described previously [40]. Briefly, samples were
Guan and Belsham, Journal of General Virology 2017;98:671–680
678
Downloaded from www.microbiologyresearch.org by
IP:  192.38.90.17
On: Wed, 17 May 2017 09:35:03
mixed with 2 Laemmli sample buffer (containing 25mM
DTT), separated by SDS-PAGE (4–15% polyacrylamide
from Bio-Rad), and transferred to PVDF membranes (Milli-
pore). After blocking in 5% nonfat dry milk and 0.1%
Tween 20 in PBS, membranes were incubated with primary
antibodies diluted in the same buffer. The following primary
antibodies were used as described [41]: monoclonal mouse
anti-FLAG 1 : 3000 dilution (Sigma); polyclonal rabbit anti-
eIF4GI (1 : 2000 dilution, kindly provided by N. Sonenberg,
McGill University, Montreal, Canada, diluted in 5% BSA);
and anti-FMDV VP2 1 : 2000 (mouse monoclonal antibody
4B2, kindly provided by L. Yu, Harbin, P. R. China). Bound
proteins were visualized using the appropriate secondary,
horseradish peroxidase-conjugated antibodies (Dako).
Detection was achieved using chemiluminescence reagents
(Pierce ECL; Thermo Fisher Scientific) and images were
captured using a Chemi-Doc XRS system (Bio-Rad).
Rescue of viruses from full-length FMDV cDNA
To introduce mutations into the FMDV full-length cDNA,
the KpnI fragment from the pSG2-derived plasmids was
ligated to KpnI-digested pT7S3-NheI [42]. The presence of
the mutations was confirmed by sequencing using primers
10PPN36 and SG57 (Table S1). The plasmids containing
the wt and mutant full-length FMDV cDNAs were linear-
ized by digestion with HpaI, then purified (Fermentas PCR
purification kit), and in vitro transcribed using T7 RNA
polymerase (Megascript kit; Ambion) as described by the
manufacturer. The RNA transcripts were analysed using
agarose gel electrophoresis and then introduced into BHK-
21 cells by electroporation as described previously [43] and
incubated at 37

C for 48 h. The viruses were harvested fol-
lowing freezing, and amplified in one or two subsequent
passages (P2 or P3) in BHK-21 cells. The appearance of
cytopathic effect (CPE) was monitored during each passage.
After these passages, when CPE was apparent, viral RNA
was extracted (QIAamp RNA Blood Mini kit; Qiagen) and
reverse transcribed using Ready-To-Go You-Prime First-
Strand Beads (GE Healthcare, Life Sciences), and amplicons
(900 bp) corresponding to the L/VP4 coding region were
amplified by PCR using primers 10PPN36 and SG57
(Table S1). The products were sequenced to confirm the
presence of the introduced mutations. Note that control
reactions, lacking reverse transcriptase, were used to show
that the PCR products obtained were derived from the viral
RNA template. Viral titres were determined, as 50% tissue
culture infectious doses (TCID50), by titration in BHK-21
cells, according to standard procedures [44].
Infection and virus growth kinetics
BHK-21, IBRS-2 and pBTY cells were grown in Dulbecco’s
modified Eagle’s medium supplemented with 5 (BHK-21
and IBRS-2) or 1% (pBTY) foetal bovine serum. Cells were
infected with either wt or mutant FMDV. After a 1 h
adsorption step, additional medium was added and the
infection was left to progress and stopped at pre-selected
times. For immunoblotting analysis, IBRS-2 cells were
infected at an m.o.i. of 2. Cells were harvested at selected
times with buffer C (as above).
For virus growth kinetics, BHK-21 and pBTY cells were
infected at an m.o.i. of 0.01 at 37

C. Infections were stopped
at selected times by freezing. Viral RNA was isolated using a
robotic protocol (MagNA Pure LC Total Nucleic Acid Isola-
tion kit, Roche) as described by the manufacturer and the
RNA samples were eluted in 50 µl of water. The production
of FMDV RNA was determined using RT-qPCR as
described previously [45, 46].
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